Literature DB >> 6158024

A haemagglutination and haemagglutination inhibition test for bluetongue virus.

N T van der Walt.   

Abstract

Haemagglutination of bluetongue virus (BTV) was demonstrated for the first time by making use of a purified preparation of the virus. The reaction was found to be independent of variations in the pH, temperature, buffer system and origin of the erythrocytes used in the test. A haemagglutination inhibition test, subsequently developed, was demonstrated to be serotype specific. The storage of the virus for indefinite periods was facilitated by lyophilization of BTV in the presence of a low concentration of sucrose.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6158024

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN： 0030-2465            Impact factor:   1.792


  9 in total

1.  Genetic reassortants for identification of the genome segment coding for the bluetongue virus hemagglutinin.

Authors:  J A Cowley; B M Gorman
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

2.  Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry.

Authors:  S S Hassan; P Roy
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins.

Authors:  T J French; J J Marshall; P Roy
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody.

Authors:  G J Letchworth; J A Appleton
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Simple procedure for preparation of bluetongue virus and epizootic hemorrhagic disease virus antigens for agar gel immunodiffusion.

Authors:  J L Stott; B I Osburn
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

6.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

7.  Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.

Authors:  Eiko Matsuo; Cristina C P Celma; Mark Boyce; Cyril Viarouge; Corinne Sailleau; Eric Dubois; Emmanuel Bréard; Richard Thiéry; Stéphan Zientara; Polly Roy
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

8.  Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep.

Authors:  Ana Cristina Pérez de Diego; Thimmasandra N Athmaram; Meredith Stewart; Belén Rodríguez-Sánchez; José Manuel Sánchez-Vizcaíno; Robert Noad; Polly Roy
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

9.  Sialic Acid Binding Sites in VP2 of Bluetongue Virus and Their Use during Virus Entry.

Authors:  Weining Wu; Polly Roy
Journal:  J Virol       Date:  2021-10-20       Impact factor: 5.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.